RTSN · Retension Pharmaceuticals, Inc. · Financials
Market Cap
$124.97M
Shares
8.33M
Volume · Oct 21
110.59K
Avg daily vol (9 sessions)
222.02K
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
No Financial Data
No structured financial facts have been ingested for this stock yet.